GERD Drugs and Devices Market Overview Highlighting Major Drivers, Trends, Growth and Demand Report 2020- 2027

Comments · 27 Views ·

The growing demand for OTC and generic drugs and the rise in the geriatric population will drive the GERD drugs and devices market.

The study on the Global GERD Drugs and Devices Market is the latest report covering the impact analysis of the currently ongoing COVID-19 pandemic. The pandemic has directly affected the market by causing disruptions in the global supply chains and indirectly by inducing financial difficulties. The growing demand for OTC and generic drugs and the rise in the geriatric population will drive the GERD drugs and devices market.GERD drugs and devices consist of various medications, devise, and surgery.

Gastroesophageal Reflux Disease is growing due to the intake of analgesics, smoking, decrease in the prevalence of Helicobacter pylori infection, consumption of certain types of food and drinks, high body mass index (BMI), family history of GERD, and limited physical activity. The growing incidence of the disease will drive the demand for the GERD drug and devices market.

Get a sample of the report : https://www.emergenresearch.com/request-sample/383

Market Scope:

One of the report’s central components is the broad GERD Drugs and Devices market segmentation that includes the product type gamut, application spectrum, end-user industry landscape, significant geographical regions, and the top market contenders. The key players’ financial positions, along with their gross profits, sales volumes, sales revenue, manufacturing costs, and other financial ratios, have been accurately gauged in the report. Furthermore, several analytical tools like investment assessment, SWOT analysis, and Porter’s Five Forces Analysis have been implemented by our analysts’ team to evaluate the production and distribution capacities of the GERD Drugs and Devices market players.

In November 2020, Sandoz Inc. announced it had shipped pantoprazole sodium to supply the hospitals for injection, 40 mg to Civica Rx. It is a part of a multiyear collaboration for the reduction in supply shortages with several other pipeline medicines.

H2 blockers are a group of drugs that reduces the amount of acid produced by the cell lining of the stomach. They are also known as histamine H2-receptor antagonists but are also known as H2 blockers. They include ranitidine, cimetidine, nizatidine, and famotidine, among others.

Key participants include Johnson Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.

TOC of the global GERD Drugs and Devices market report:

Chapter 1, describes the GERD Drugs and Devices Introduction, market overview, product offerings, growth opportunities, market risks, driving forces, and challenges.

Chapter 2, analyzes the key manufacturers of GERD Drugs and Devices, along with the sales, revenue, and price of GERD Drugs and Devices, in the forecast period.

Chapter 3, studies the competitive situation among the major manufacturers and vendors, with sales, revenue, and market share.

Chapter 4, analyzes the global market by regions, with sales, revenue, and market share of GERD Drugs and Devices, for each region, from 2020 to 2027.

Chapters 5, 6, 7, 8 and 9, analyze the GERD Drugs and Devices market by type, application, regions, and manufacturers, with sales, revenue, and market share by key countries in these regions…Continued

Request a discount on the report : https://www.emergenresearch.com/request-discount/383

For the purpose of this report, Emergen Research has segmented into the global GERD Drugs and Devices Market on the basis of route of administration, drug type, device type, and region:

  • Route Of Administration Outlook (Revenue, USD Billion; 2017-2027)
    • Oral
    • Parenteral
  • Drug Type Outlook (Revenue, USD Billion; 2017-2027)
    • H2 Receptor Antagonist
    • Proton Pump Inhibitor (PPIs)
    • Antacids
  • Device Type Outlook (Revenue, USD Billion; 2017-2027)
    • MUSE –Medigus Ultrasonic Surgical Endostapler
    • LINX Management System
    • Stretta Therapy
    • Bravo Reflux Testing System
    • Digitrapper reflux testing system
    • Others

Key Points of GERD Drugs and Devices Market:

Extensive coverage of the analysis of the GERD Drugs and Devices market

Key insights into the regional spread of the industry in key geographies

Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market

Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the GERD Drugs and Devices market

Complete data about the key manufacturers and vendors in the GERD Drugs and Devices market

 

 

Read More: https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market

Related Reports:

Assessment Services Market: https://www.emergenresearch.com/industry-report/assessment-services-market

3D Printing Market: https://www.emergenresearch.com/industry-report/3d-printing-market

Digital Scent Technologies Market: https://www.emergenresearch.com/industry-report/digital-scent-technologies-market

FinFET Technology Market: https://www.emergenresearch.com/industry-report/finfet-technology-mark 

Lighting as a Service Market: https://www.emergenresearch.com/industry-report/lighting-as-a-service-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research         and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

 

 

Comments